Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Shaw

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Lancet. Respiratory Medicine|November 18, 2023
Nasally delivered SARS-CoV-2 vaccines: future promise and challengesRobert H Shaw
Wake Forest Law Review|January 1, 1976
Constitutional law--legislative naiveté in involuntary sterilization lawsRobert H Shaw
BMC Infectious Diseases|December 12, 2018
Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?Shannon A Gunawardana, Robert H Shaw
Revista Medica Herediana : Organo Oficial De La Facultad De Medicina "Alberto Hurtado", Universidad Peruana Cayetano Heredia, Lima, Peru|April 25, 2018
[Reliability of Commercial Tests for Hepatitis C Virus]Robert H Shaw, Krishna P Reddy, Jorge Coronel, et al.
Lancet (London, England)|May 15, 2021
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataRobert H Shaw, Arabella Stuart, Melanie Greenland, et al.
Plos Medicine|October 12, 2021
Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort studyYin Mo, David W Eyre, Sheila F Lumley, et al.
Lancet (London, England)|December 23, 2021
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serumWanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, et al.
Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Ebiomedicine|July 17, 2025
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222)Sandra Belij-Rammerstorfer, Emma Sheehan, Grace Li, et al.
Nature Medicine|October 13, 2022
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infectionAlexander J Mentzer, Daniel O'Connor, Sagida Bibi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Lancet. Respiratory Medicine|November 18, 2023
Nasally delivered SARS-CoV-2 vaccines: future promise and challengesRobert H Shaw
Wake Forest Law Review|January 1, 1976
Constitutional law--legislative naiveté in involuntary sterilization lawsRobert H Shaw
BMC Infectious Diseases|December 12, 2018
Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?Shannon A Gunawardana, Robert H Shaw
Revista Medica Herediana : Organo Oficial De La Facultad De Medicina "Alberto Hurtado", Universidad Peruana Cayetano Heredia, Lima, Peru|April 25, 2018
[Reliability of Commercial Tests for Hepatitis C Virus]Robert H Shaw, Krishna P Reddy, Jorge Coronel, et al.
Lancet (London, England)|May 15, 2021
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataRobert H Shaw, Arabella Stuart, Melanie Greenland, et al.
Plos Medicine|October 12, 2021
Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort studyYin Mo, David W Eyre, Sheila F Lumley, et al.
Lancet (London, England)|December 23, 2021
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serumWanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, et al.
Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Ebiomedicine|July 17, 2025
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222)Sandra Belij-Rammerstorfer, Emma Sheehan, Grace Li, et al.
Nature Medicine|October 13, 2022
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infectionAlexander J Mentzer, Daniel O'Connor, Sagida Bibi, et al.
Pageof 2